-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Sell on Rocket Pharmaceuticals, Raises Price Target to $3

Benzinga·03/02/2026 17:26:37
Listen to the news
Goldman Sachs analyst Richard Law maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Sell and raises the price target from $2 to $3.